Notwithstanding its role as an angiotensin-converting enzyme, a more direct effect of chymase in cleaving endothelial tight junctions or potential contributions of other MC products, such as tryptase and serotonin (12), in COVID-19–related vascular pathologies cannot be ruled out. This evidence concerns the gene CMA1 and COVID-19.